{"id":"oxaflumazine","rwe":[{"pmid":"4148298","year":"1972","title":"[Metabolism of oxaflumazine].","finding":"","journal":"Annales pharmaceutiques francaises","studyType":"Clinical Study"},{"pmid":"4405378","year":"1972","title":"[Pilot study on oxaflumazine, a new piperazinated phenothiazine].","finding":"","journal":"International journal of clinical pharmacology, therapy and toxicology","studyType":"Clinical Study"},{"pmid":"4403943","year":"1972","title":"[Neuroleptic effect of oxaflumazine, especially in acute psychoses].","finding":"","journal":"Therapeutique (La Semaine des hopitaux)","studyType":"Clinical Study"},{"pmid":"5055026","year":"1972","title":"[Experimental study of oxaflumazine acid disuccinate in the treatment of 24 cases of psychotic children in a pedopsychiatric environment].","finding":"","journal":"Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance","studyType":"Clinical Study"},{"pmid":"5113801","year":"1971","title":"[Pharmacological study of a new neuroleptic derivated drug: oxaflumazine].","finding":"","journal":"Therapie","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["oxaflumazine succinate","oxaflumazine","oxaflumazine disuccinate","SD 270-31"],"offLabel":[],"synonyms":["oxaflumazine succinate","oxaflumazine","oxaflumazine disuccinate","SD 270-31"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and OXAFLUMAZINE is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on the specific lock and the key's shape. This can help regulate various cellular processes, but the exact details of how OXAFLUMAZINE works are still unknown.","oneSentence":"OXAFLUMAZINE is a small molecule that interacts with specific biological pathways to produce its effects.","technicalDetail":"OXAFLUMAZINE is a small molecule that modulates biological activity through interaction with a specific target, although the identity of this target is currently unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3803","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXAFLUMAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:09:45.899660","biosimilars":[],"competitors":[],"genericName":"oxaflumazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"0ME957NZRY","CHEBI":"CHEBI:135808","INN_ID":"2175","UMLSCUI":"C0069710","ChEMBL_ID":"CHEMBL2107063","PUBCHEM_CID":"62862","SECONDARY_CAS_RN":"7450-97-7","MESH_SUPPLEMENTAL_RECORD_UI":"C005286"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1972 Dec","pmid":"4148298","title":"[Metabolism of oxaflumazine].","journal":"Annales pharmaceutiques francaises"},{"date":"1972 Aug","pmid":"4405378","title":"[Pilot study on oxaflumazine, a new piperazinated phenothiazine].","journal":"International journal of clinical pharmacology, therapy and toxicology"},{"date":"1972 May-Jun","pmid":"4403943","title":"[Neuroleptic effect of oxaflumazine, especially in acute psychoses].","journal":"Therapeutique (La Semaine des hopitaux)"},{"date":"1972 Mar-Apr","pmid":"5055026","title":"[Experimental study of oxaflumazine acid disuccinate in the treatment of 24 cases of psychotic children in a pedopsychiatric environment].","journal":"Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance"},{"date":"1971 May-Jun","pmid":"5113801","title":"[Pharmacological study of a new neuroleptic derivated drug: oxaflumazine].","journal":"Therapie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"OXAFLUMAZINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OXAFLUMAZINE is a small molecule with the synonyms OXAFLUMAZINA, OXAFLUMAZINE, SD 270-31 FREE BASE, and SD-270-31 FREE BASE.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}